KMC Speciality Hospitals (India) Share Price
137.20-0.65 (-0.47%)
+101.94% past 1 Year
KMC hospital‚ in its decennial year of operations has added numerous feathers to its cap. From a humble beginning of 30 beds in 1999 we have come a long way
Corporate filings & documents
Announcements
A copy of the Business Responsibility and Sustainability Report for FY 2025-26 is enclosed.
20 hours agoA copy of the Business Responsibility and Sustainability Report for FY 2025-26 is enclosed.
20 hours agoIn terms of Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 a copy of the Annual Report of the Company for the Financial year 2025-26 along with the Notice of the 43rd AGM is enclosed.
20 hours agoIn terms of Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 a copy of the Annual Report of the Company for the Financial year 2025-26 along with the Notice of the 43rd AGM is enclosed.
20 hours agoA copy of the Notice of the 43rd AGM is enclosed.
21 hours agoA copy of the Notice of the 43rd AGM is enclosed.
21 hours agoInvestor presentation for the quarter ended 30th June 2026
6 days agoInvestor presentation for the quarter ended 30th June 2026
6 days agoNewspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company
2 weeks agoNewspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company
2 weeks agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015: (i) Intimation of approval of new capacity expansion/ hospital projects at Trichy and Bengaluru; & (ii) Appointment of Cost Auditor
3 weeks agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015: (i) Intimation of approval of new capacity expansion/ hospital projects at Trichy and Bengaluru; & (ii) Appointment of Cost Auditor
3 weeks agoPlease find enclosed the Standalone Unaudited Financial results for the quarter ended 30th June 2026 along with the Limited Review Report of the Statutory Auditors as approved by the Board of Directors at their meeting held today 14th August 2026.
3 weeks agoPlease find enclosed the Standalone Unaudited Financial results for the quarter ended 30th June 2026 along with the Limited Review Report of the Statutory Auditors as approved by the Board of Directors at their meeting held today 14th August 2026.
3 weeks agoPlease find enclosed the Standalone Unaudited Financial results for the Quarter ended 30th June 2026 along with the Limited Review Report of the Statutory Auditors as approved by the Board of Directors at their meeting held today 14th August 2026
3 weeks agoPlease find enclosed the Standalone Unaudited Financial results for the Quarter ended 30th June 2026 along with the Limited Review Report of the Statutory Auditors as approved by the Board of Directors at their meeting held today 14th August 2026
3 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
3 weeks agoKMC Speciality Hospitals (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve The unaudited financial results of the Company for the quarter ended 30th June 2026
3 weeks agoKMC Speciality Hospitals (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve The unaudited financial results of the Company for the quarter ended 30th June 2026
3 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 05 2026 for Sri Kauvery Medical Care (India) Ltd
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 05 2026 for Sri Kauvery Medical Care (India) Ltd
1 month agoPlease find enclosed a copy of the certificate dated July 3 2026 received from our RTA for the quarter ended June 30 2026
1 month agoPlease find enclosed a copy of the certificate dated July 3 2026 received from our RTA for the quarter ended June 30 2026
1 month agoIntimation of Closure of Trading Window for the quarter ending 30th June 2026
2 months agoIntimation of Closure of Trading Window for the quarter ending 30th June 2026
2 months agoNewspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company
2 months agoNewspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company
2 months agoInvestor Presentation for the quarter and year ended 31st March 2026
3 months agoInvestor Presentation for the quarter and year ended 31st March 2026
3 months agoPursuant to Regulation 24A of SEBI (LODR) Regulations 2015 please find enclosed the Annual Secretarial Compliance Report of the Company for the financial year ended March 31 2026 duly certified by the Practicing Company Secretary.
3 months agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Purchase of vacant land by the Company
3 months agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Purchase of vacant land by the Company
3 months agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Appointment of Internal Auditor for FY 2026-27
3 months agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Appointment of Internal Auditor for FY 2026-27
3 months agoPlease find enclosed the Standalone Audited Financial Results for the FY 2025-26
3 months agoPlease find enclosed the Standalone Audited Financial Results for the FY 2025-26
3 months agoPlease find enclosed the Standalone Audited Financial results for the Quarter and Year ended 31st March 2026 along with the Auditors Report as approved by the Board of Directors at their meeting held today 29th May 2026. Pursuant to Regulation 33(3)(d) of the SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 declaration by the Company with respect to Auditors Report with unmodified opinion is also enclosed.
3 months agoPlease find enclosed the Standalone Audited Financial results for the Quarter and Year ended 31st March 2026 along with the Auditors Report as approved by the Board of Directors at their meeting held today 29th May 2026. Pursuant to Regulation 33(3)(d) of the SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 declaration by the Company with respect to Auditors Report with unmodified opinion is also enclosed.
3 months agoKMC Speciality Hospitals (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve The Audited financial results of the Company for the quarter and financial year ended 31st March 2026
3 months agoKMC Speciality Hospitals (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve The Audited financial results of the Company for the quarter and financial year ended 31st March 2026
3 months agoNewspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company
4 months agoNewspaper publication regarding Special Window for transfer and dematerialisation of physical shares of the Company
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>KMC Speciality Hospitals (India) Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110TN1982PLC009781</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>71.35</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA-</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Indumathi P <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: K Anand Babu <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 17/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>KMC Speciality Hospitals (India) Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110TN1982PLC009781</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>71.35</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA-</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Indumathi P <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: K Anand Babu <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 17/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoPlease find enclosed a copy of the certificate dated April 6 2026 received from our RTA for the quarter ended March 31 2026.
4 months agoPlease find enclosed a copy of the certificate dated April 6 2026 received from our RTA for the quarter ended March 31 2026.
4 months agoInvestor Presentation for the quarter and nine months ended December 31 2025
5 months agoInvestor Presentation for the quarter and nine months ended December 31 2025
5 months agoIntimation of Closure of Trading Window for the quarter and year ending 31st March 2026
5 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
No. 6 Royal Road Cantonment Trichy Tamil Nadu PIN: 620001 Tel No: 0431 - 4407777 Fax No: 0431 - 2415402 Email: [email protected] Internet: www.kauveryhospital.com
Registrars
Subramanian Buildings No 1 , Club House Road,,Chennai Subramanian Buildings No 1 Club House Road NULL PIN: Tel No: 044-28460390/28460394 Fax No: 044-28460129 Email: NULL
Management
Indumathi P, Company Secretary & Compliance Officer
S Chandrakumar, Chairman
S Manivannan, Managing Director
T Senthil Kumar, Non Independent & Non Executive Director
S Vijayabaskaran, Non Independent & Non Executive Director
Sunil Satyapal Gulati, Non Executive Independent Director
Ravichandran Purushothaman, Non Executive Independent Director
N Jeyanthei, Non Executive Independent Director
Mohan Srinivasan, Non Executive Independent Director
Details
BSE 524520
NSE KMCSHIL
ISIN INE879K01018